The DOI matches its Crossref record; 67 of the 69 references it cites were found in a registry or an index; 21 of the 67 sources its claims cite were checked for support.
The experience of Anxiety for people with Parkinson’s disease
Open accessAbstract
Anxiety is a common non-motor symptom of Parkinson’s disease (PD) associated with increased disability and reduced quality of life. However, anxiety is poorly understood, underdiagnosed, and undertreated. To date, little research has explored how anxiety is experienced by patients themselves. This study explored the experience of anxiety for people with Parkinson’s (PWP) to inform future research and interventions. Semi-structured interviews with 22 PWP (aged 43-80, 50% female) were conducted and analysed using inductive thematic analysis. Four main themes were extracted: conceptualising anxiety; anxiety and the body; anxiety and social identity; and coping with anxiety. Sub-themes revealed inconsistent perceptions: anxiety was in body and mind, part of disease and human nature, part of self-identity and a threat to it. The symptoms described were diverse. Many perceived their anxiety as more incapacitating than motor symptoms or capable of amplifying them, and described that anxiety restricted their lifestyle. All perceived anxiety as connected to PD, and ultimately persistent: dominant aspirations were coping and acceptance rather than cures, with medications strongly resisted. Findings highlight the complexity and high importance of anxiety for PWP. Implications for therapeutic approaches are discussed. © 2023, The Author(s).
Overview
CoChat Summary
TL;DR
This qualitative study interviewed 22 people with Parkinson’s disease (PWP) who self-reported anxiety and found that anxiety was experienced as physical, social, and identity-changing, often felt as persistent and sometimes more incapacitating than motor symptoms. Participants generally wanted coping and acceptance rather than cure, and many resisted medication.
Key findings
- Semi-structured interviews with 22 PWP (aged 43–80, 50% female) identified four themes: conceptualising anxiety; anxiety and the body; anxiety and social identity; and coping with anxiety.
- Anxiety was widely experienced as bodily: all but three participants perceived it as a physical experience, and many described symptoms such as shallow breathing, nausea, heat, increased tremor, stiffness, and “shaking on the inside.”
- Participants often saw anxiety as tied to Parkinson’s disease and as persistent: all thought it was related to PD in some way, and some said it was “one of the earliest and most incapacitating PD symptoms.”
- Coping aspirations centered on acceptance and self-management; two-thirds perceived they could cope with anxiety, while a third felt they had no control over it, and a few reported suicidal thoughts.
Methods
- Qualitative design within the larger AND-PD study; in-depth semi-structured interviews were conducted remotely between March and April 2022.
- Sample: 22 UK participants aged 18–89 were eligible if they had a confirmed PD diagnosis and self-reported anxiety; recruitment used maximum variation sampling across disease stages and was balanced by sex (11 men, 11 women).
- Analysis: interviews were transcribed verbatim and analyzed in NVivo 12 using Braun and Clarke’s reflexive inductive thematic analysis; the team compared themes across sex and PAS anxiety threshold groups.
Limitations
- The paper states that a more diverse sample could have enriched interpretations, including participants from different cultures and those with severe functional disability.
- It notes that interviews were read only by EB, who had no formal training in clinical psychology; although themes were discussed with JS, this remains a potential limitation stated by the authors.
- Evident from the text: anxiety was self-reported and the GAD-7/PAS timing differed from interviews (median intervals 65 days and 68 days), so measured anxiety may not fully match participants’ experiences at interview.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 5 Not valid · 30 Not checked · 112 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Detection is complicated by overlapping symptoms such as tremor, fatigue, and loss of appetite, as well as PD-specific symptoms such as increased freezing of gait16,17.”
§ The experience of Anxiety for people with Parkinson’s disease > Introduction
What the sources say
- Partly supportedcites [16] Ehgoetz Martens, K. A., Ellard, C. G. & Almeida, Q. J. Does anxiety cause freezing of gait in Parkinson’s disease? PLoS One 9, ee106561–ee106561 (2014). sourceExperimental — accuracy not yet measured
The Results (‘Freezing of gait measures’; page not provided) report more freezing episodes and a greater proportion of time frozen in the high-anxiety condition, supporting the increased-freezing portion. The paper does not say that overlapping symptoms such as tremor, fatigue, or loss of appetite complicate detection of anxiety, or that freezing itself creates a detection problem. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [17] Avanzino, L., Lagravinese, G., Abbruzzese, G. & Pelosin, E. Relationships between gait and emotion in Parkinson’s disease: a narrative review. Gait Posture 65, 57–64 (2018). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“prospective evidence shows that anxiety is higher than in controls in medication-naïve patients at diagnosis20,21”
§ The experience of Anxiety for people with Parkinson’s disease > Introduction
What the sources say
- Partly supportedcites [20] Dlay, J. K. et al. Progression of neuropsychiatric symptoms over time in an incident parkinson’s disease cohort (ICICLE-PD). Brain Sci. 10, 78 (2020). sourceExperimental — accuracy not yet measured
Results §3.1 reports significantly more anxiety in newly diagnosed Parkinson’s patients than controls at baseline (29.6% versus 9.3%). However, the Discussion explicitly says participants were not drug naïve, and Results places baseline an average of 6.1 months after diagnosis. The medication-naïve and at-diagnosis qualifiers are therefore not supported by this study. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [21] Shiba, M. et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov. Disord. 15, 669–677 (2000). doi:10.1002/1531-8257(200007)15:4
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“can be more challenging to live with than motor symptoms7,8”
§ The experience of Anxiety for people with Parkinson’s disease > Introduction
What the sources say
- Could not verifycites [7] Zhang, A. et al. Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality. Int. Psychogeriatr. https://doi.org/10.1017/S1041610221002866 (2022). sourceExperimental — accuracy not yet measured
The Measures section describes assessments of Parkinson’s severity, coping and caregiver burden, but not an assessment comparing anxiety with motor symptoms. Searches for anxiety and for that comparison found no passage in our copy saying anxiety can be more challenging to live with. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [8] Balestrino, R. & Martinez-Martin, P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. J. Neurol. Sci. 373, 173–178 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“retrospective evidence shows anxiety can predate motor symptoms by two decades”
§ The experience of Anxiety for people with Parkinson’s disease > Introduction
What the sources say
- Could not verifycites [20] Dlay, J. K. et al. Progression of neuropsychiatric symptoms over time in an incident parkinson’s disease cohort (ICICLE-PD). Brain Sci. 10, 78 (2020). sourceExperimental — accuracy not yet measured
The Introduction and Results describe anxiety in people with newly diagnosed Parkinson’s disease, and the Discussion reports findings over a 36-month follow-up. Our copy does not address whether anxiety predates motor symptoms by two decades; searches for that phrase and for retrospective evidence of anxiety before motor symptoms found no supporting passage. Page numbers were not available in our copy. (LLM, conf=0.73)
- Not checked — no full text of the sourcecites [21] Shiba, M. et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov. Disord. 15, 669–677 (2000). doi:10.1002/1531-8257(200007)15:4
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“To date, few pharmacological or psychological treatments have been clearly demonstrated as effective in trials4–6”
§ The experience of Anxiety for people with Parkinson’s disease > Introduction
What the sources say
- Not checked — no full text of the sourcecites [4] Pontone, G. M. & Mills, K. A. Optimal treatment of depression and anxiety in Parkinson’s disease. Am. J. Geriatr. Psychiatry 29, 530–540 (2021). source
- Supportedcites [5] Moonen, A. J. H. et al. Cognitive behavioral therapy for anxiety in Parkinsonʼs disease: a randomized controlled trial. Mov. Disord. 36, 2539–2548 (2021). source
The introduction (p. 2) says there had been no randomized placebo-controlled trials of commonly used anxiety medications in Parkinson’s disease and no prior RCTs of CBT for anxiety. The Results and Conclusion (p. 1) report that this trial found CBT effective on the Parkinson Anxiety Scale, supporting the claim that few treatments had been clearly demonstrated effective in trials. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [6] Zhang, Q., Yang, X., Song, H. & Jin, Y. Cognitive behavioral therapy for depression and anxiety of Parkinson’s disease: a systematic review and meta-analysis. Complement Ther. Clin. Pr. 39, 101111 (2020). source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
85 more claims · 4 with their cited sources checked
Create a free account to see all 163 claims and every source verdict.
- Borderline: one of the tests for a substantial claim is unclear. 3
- Probably not a substantial claim. 39
- It may state two separate claims as one. 45
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many individuals with PD experience significant anxiety and depression, often related to fears about disease progression and loss of independence (Blundell et al., 2023).”
From A Systematic Review of Third-Wave Therapies to Reduce Distress and Improve Wellbeing and Quality of Life in People with Parkinson's Disease. (2025) · cites this paper as Blundell et al., 2023
Experimental — accuracy not yet measured
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability
Guest, G., Bunce, A., & Johnson, L. (2006) · Field Methods · doi:10.1177/1525822x05279903 · Cited by 20,808
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Early pathophysiological changes to brainstem structures involved in stress responses, including the raphe nucleus, rich in serotonin, and the locus ceruleus, rich in noradrenaline, are two candidate mechanisms 24 .”
One size fits all? What counts as quality practice in (reflexive) thematic analysis?
Braun, V., & Clarke, V. (2021) · Qualitative Research in Psychology · doi:10.1080/14780887.2020.1769238 · Cited by 9,727
Social Relationships and Mortality Risk: A Meta-analytic Review
Holt-Lunstad, J., Smith, T. B., & Layton, J. B. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000316 · Cited by 7,272 · cited 1×
“Importantly, avoidance perpetuates anxiety as it minimises opportunities to discon fi rm perceived threats; it also may lead to social network attrition or loneliness, which could negatively impact health and well-being over time 48 and lead to overall worse outcomes.”
Acceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 1×
“This suggests third-wave behavioural therapies, such as acceptance and commitment therapy (ACT) and mindfulness-based therapy (MBT) may be bene fi cial 55,56 .”
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Thematic Analysis: A Practical Guide
Braun, V., & Clarke, V. (2022) · QMiP Bulletin · doi:10.53841/bpsqmip.2022.1.33.46 · Cited by 5,438
Research works printed but not linked: 3
- Markus, H. & Kitayama, S. Culture and the self. Implic. Cogn. Emot. Motiv. 98, 224–253 (1991).
- Kaplan, W. & Wirtz, V. Priority medicines for Europe and the World. Update 2013 Rep. Methodol. 2, 99–102 (2013).
- Maxwell, J. A Realist Approach For Qualitative Research (SAGE Publications, (2012).
Cited by
Microbial signatures and therapeutic strategies in neurodegenerative diseases
Rob, M., Yousef, M., Lakshmanan, A. P., Mahboob, A., Terranegra, A., & Châari, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117905 · Cited by 46
Emotion in action: When emotions meet motor circuits
Braine, A., & Georges, F. E. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105475 · Cited by 39
Exploring Risk and Protective Factors in Parkinson’s Disease
Beheshti, I. (2025) · Cells · doi:10.3390/cells14100710 · Cited by 22
“Research shows that individuals under 50 years of age with mental health disorders, including schizophrenia, bipolar disorder, insomnia, depression, and anxiety, are at a heightened risk of PD, particularly when other environmental or contributory factors are present [176,177].”
Packer, E., Debelle, H., Bailey, H. G. B., Rehman, R. Z. U., Yarnall, A. J., Rochester, L., Alcock, L., & Din, S. D. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00943-y · Cited by 19
Deng, Q., Parker, E., Wu, C., Zhu, L., Liu, T. C., Duan, R., & Yang, L. (2024) · Aging and Disease · doi:10.14336/ad.2024.0239 · Cited by 12
“…PD patients remains elusive, as it is uncertain whether neurochemical alterations inherent to the disease itself, psychological responses to the stresses associated with the condition, medication-related effects, or external factors unrelated to PD contribute to the anxiety levels observed [278].”
Metadata
- Authors
- Blundell, E. K., Grover, L. E., Stott, J., & Schrag, A.
- Affiliations
- University College London (GB)
- Corresponding author
- Schrag, Anette
- Venue
- npj Parkinson's Disease
- Published
- 2023-05-17
- Volume
- 9
- Issue
- 1
- Pages
- 75-75
- ISSN
- 2373-8057 (ISSN-L)
- PMC
- PMC10192312
- OpenAlex
- W4377011060
- Cited by
- 41
- References
- 69
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 7 · 2023: 5
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Parkinson s Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute for Health and Care Research
- European Commission (848002, HORIZON2020)
- University College London Hospitals Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, anxiety, lived experience, non-motor symptoms, social identity, coping, acceptance, drug resistance, quality of life, disability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The experience of Anxiety for people with Parkinson’s disease. https://app.cochat.ai/papers/10.1038/s41531-023-00512-1
- The paper
- Blundell, E. K., Grover, L. E., Stott, J., & Schrag, A. (2023). The experience of Anxiety for people with Parkinson’s disease. npj Parkinson's Disease. https://doi.org/10.1038/s41531-023-00512-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.